CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Exercise or conversion CSO, Head Res.&Non-Clin. Dev. acquired 5,130 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.58 ($51,450)
- 4 Open-market sale President and CEO sold 14,340 shares at $20.60 ($295,404)
- 4 Open-market sale President and CEO sold 14,342 shares at $19.86 ($284,832)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.00 ($50,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Open-market sale President and CEO sold 19,120 shares at $24.13 ($461,366)
- 4 Open-market sale CSO, Head Res.&Non-Clin. Dev. sold 48,368 shares at $24.34 ($1,177,277)
- 4 Open-market sale Director sold 10,000 shares at $24.27 ($242,680)
- 4 Open-market sale President and CEO sold 9,562 shares at $18.57 ($177,566)
- 4 Open-market sale 10% owner sold 24,777 shares at $24.34 ($603,072)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $18.10 ($45,250)
- 4 Open-market sale Director sold 5,000 shares at $17.30 ($86,476)
- 4/A Open-market sale President and CEO sold 9,930 shares at an average $17.33 ($172,054)
- 4/A Open-market sale President and CEO sold 18,756 shares at an average $17.50 ($328,260)
- 4 Open-market sale 10% owner sold 20,000 shares at $18.00 ($360,000)
- 4 Open-market sale Chief Financial Officer sold 2,500 shares at $17.17 ($42,925)
- 4 Open-market sale President and CEO sold 9,930 shares at $17.32 ($171,988)
Page 14 of 20 · 400 filings